NL-OMON36420
Withdrawn
Phase 2
Phase II study: Radiofrequency ablation of irresectable locally advanced pancreatic cancer - Phase II: RFA of LAPC
niversitair Medisch Centrum Utrecht0 sites15 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- cancer of the pancreas
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 15
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with locally advanced pancreatic cancer
- •2\. No evidence of systemic metastasis, CT scan within 1 month prior to inclusion
- •3\. No serious medical or psychological condition precluding radiofrequency ablation
- •4\. Fully informed written consent given
- •5\. Patients willing to attend for three months follow\-up
Exclusion Criteria
- •1\. Patients younger than 18 years
- •2\. Pregnancy
- •3\. Patients with distant metastasis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study: Radiofrequency ablation of locally advanced pancreatic cancercancer of the pancreasPancreatic cancer10015674NL-OMON37585niversitair Medisch Centrum Utrecht17
Completed
Phase 2
Phase II study on radiofrequency ablation in early breast cancerJPRN-UMIN000020805Department of Breast Surgery, School of Medicine Kyorin University29
Recruiting
Phase 2
Phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal componentsJPRN-UMIN000013836Department of Breast Surgery, School of Medicine Kyorin University32
Completed
Not Applicable
A clinical trial to study efficacy and safety of pulsed radiofrequency as treatment of oral cancer pain.CTRI/2016/08/007179Post Graduate Institute of Medical Education Research30
Recruiting
Not Applicable
Prospective evaluation of radiofrequency ablation for benign biliary stricturesBenign biliary strictureJPRN-UMIN000040155Aichi Medical University20